Shanghai ZJ Bio-Tech Co

Shanghai ZJ Bio-Tech Co Liabilities

The The Liabilities of Shanghai ZJ Bio-Tech Co (688317.SS) as of Nov 16, 2026 is 414.95 M CNY. In the previous year, The Liabilities was 153.06 M CNY — a change of 171.10% (higher).

Liabilities

414.95 MCNY

YoY

171.10%

Last updated:

In 2025, Shanghai ZJ Bio-Tech Co's total liabilities amounted to 414.95 M CNY, a 171.10% difference from the 153.06 M CNY total liabilities in the previous year.

The Shanghai ZJ Bio-Tech Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
46.98 M CNY
Jan 1, 2019
70.09 M CNY
Jan 1, 2020
416.97 M CNY
Jan 1, 2021
427.27 M CNY
Jan 1, 2022
543.44 M CNY
Jan 1, 2023
249.25 M CNY
Jan 1, 2024
153.06 M CNY
Jan 1, 2025
414.95 M CNY
The Shanghai ZJ Bio-Tech Co Liabilities history
YEARLiabilitiesYoY
414.95 MCNY+171.10%
153.06 MCNY-38.59%
249.25 MCNY-54.13%
543.44 MCNY+27.19%
427.27 MCNY+2.47%
416.97 MCNY+494.94%
70.09 MCNY+49.20%
46.98 MCNY+8.18%
43.42 MCNY+1.78%
42.66 MCNY-16.06%
50.82 MCNY-43.07%
89.28 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai ZJ Bio-Tech Co Stock analysis

What does Shanghai ZJ Bio-Tech Co do? Shanghai ZJ Bio-Tech Co., Ltd. generates revenue through the research, development, production, and sale of molecular diagnostic reagents and instruments. The company's primary products are nucleic acid detection kits and molecular diagnostic instruments, which are sold to customers in sectors including emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The firm focuses its business activities within the domestic market, targeting institutions and organizations requiring diagnostic solutions for public health and clinical applications. The company's business model centers on providing diagnostic reagents and equipment for critical applications such as emergency public health safety and medical clinical diagnosis. Its products are designed to meet the needs of domestic customers in healthcare, public safety, and food safety sectors, with a strong emphasis on molecular diagnostics. Shanghai ZJ Bio-Tech leverages its domestic market presence to serve institutions requiring reliable diagnostic tools for health and safety monitoring. Shanghai ZJ Bio-Tech Co., Ltd. operates with a domestic market focus, selling its molecular diagnostic instruments and reagents to entities involved in public health, clinical diagnosis, and food safety. The firm's revenue streams are derived from the sale of nucleic acid detection kits and molecular diagnostic instruments, which are essential for applications in emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. Shanghai ZJ Bio-Tech Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Shanghai ZJ Bio-Tech Co's Liabilities

Shanghai ZJ Bio-Tech Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Shanghai ZJ Bio-Tech Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Shanghai ZJ Bio-Tech Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Shanghai ZJ Bio-Tech Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Shanghai ZJ Bio-Tech Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Shanghai ZJ Bio-Tech Co stock

The Liabilities of Shanghai ZJ Bio-Tech Co is 414.95 M CNY in 2025.

The Liabilities of Shanghai ZJ Bio-Tech Co changed from 153.06 M CNY to 414.95 M CNY, representing a 171.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Shanghai ZJ Bio-Tech Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Shanghai ZJ Bio-Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Shanghai ZJ Bio-Tech Co

All Key Metrics — Shanghai ZJ Bio-Tech Co